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Abstract
Background: The Theoretical Domains Framework (TDF) is a set of 14 domains of behavior change that provide a
framework for the critical issues and factors influencing optimal knowledge translation. Considering that a previous
study has identified optimal knowledge translation techniques for each TDF domain, it was hypothesized that the
TDF could be used to contextualize and interpret findings from a behavioral and educational needs assessment. To
illustrate this hypothesis, findings and recommendations drawn from a 2012 national behavioral and educational
needs assessment conducted with healthcare providers who treat and manage Growth and Growth Hormone
Disorders, will be discussed using the TDF.
Methods: This needs assessment utilized a mixed-methods research approach that included a combination of: [a]
data sources (Endocrinologists (n:120), Pediatric Endocrinologists (n:53), Pediatricians (n:52)), [b] data collection
methods (focus groups, interviews, online survey), [c] analysis methodologies (qualitative - analyzed through
thematic analysis, quantitative - analyzed using frequencies, cross-tabulations, and gap analysis). Triangulation was
used to generate trustworthy findings on the clinical practice gaps of endocrinologists, pediatric endocrinologists,
and general pediatricians in their provision of care to adult patients with adult growth hormone deficiency or
acromegaly, or children/teenagers with pediatric growth disorders. The identified gaps were then broken into key
underlying determinants, categorized according to the TDF domains, and linked to optimal behavioral change
techniques.
Results: The needs assessment identified 13 gaps, each with one or more underlying determinant(s). Overall, these
determinants were mapped to 9 of the 14 TDF domains. The Beliefs about Consequences domain was identified as
a contributing determinant to 7 of the 13 challenges. Five of the gaps could be related to the Skills domain, while
three were linked to the Knowledge domain.
Conclusions: The TDF categorization of the needs assessment findings allowed recommendation of appropriate
behavior change techniques for each underlying determinant, and facilitated communication and understanding of
the identified issues to a broader audience. This approach provides a means for health education researchers to
categorize gaps and challenges identified through educational needs assessments, and facilitates the application of
these findings by educators and knowledge translators, by linking the gaps to recommended behavioral change
techniques.
Keywords: Theoretical domains framework, Application of educational research, Needs assessment,
Mixed–methods, Behavioral change techniques, Knowledge translation, Endocrinology, Adult growth hormone
deficiency, Acromegaly, Pediatric growth disorders
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Knowledge translation (KT) theories recognize that health-
care environments are complex and dynamic systems, with
multiple factors and stakeholders of influence [1,2]. Over
the years, various models and theories of behavioral, psy-
chological, and/or socio-cultural investigation have been
used in KT research. This article proposes using one such
model, the Theoretical Domains Framework (TDF), to
contextualize and interpret findings from a behavioral and
educational needs assessment, a study aiming to identify
the clinical behavior gaps (defined as the difference between
“what is”–what the healthcare providers are doing - and
“what should be”–the best practices) [3] and educational
needs of a given healthcare provider population. The fol-
lowing introduction will briefly present the TDF, before
providing details of the clinical background of the needs as-
sessment, which was conducted with healthcare providers
who treat and manage patients with growth and growth
hormone (GH) disorders.
The theoretical domains framework
To provide structure to the emergence of multiple KT
models, Michie and colleagues [4] detailed the results of
a consensus process that aimed to unify multiple health,
social and psychological theories relevant to KT re-
search. Three groups of contributors, comprised of spe-
cialists in psychological theory, health services research,
and health psychology were involved in a 6-phase
process. The result was the Theoretical Domains Frame-
work (TDF), a set of 12 domains of behavior change that
was subsequently updated to 14 [5]. These 14 domains
provide a comprehensive framework for critical issues
and factors influencing optimal KT and educational re-
search incorporating individual, interpersonal, systems
and contextual variables, that is not tied to any specific
medical approach or therapeutic area.
To date, the TDF has been deployed in two ways [6]. The
first use is referred to as Theoretical Domains Interviewing
(TDI) [7,8], and is applied to interviews with groups need-
ing performance change. Group members report barriers
and enablers that are analyzed using TDF domains, enab-
ling optimal design of an intervention to implement the
needed performance change. Secondly, studies have identi-
fied optimal behavioral change techniques for each domain,
in order to support educators in the selection of the most
appropriate technique for KT, performance change and/or
educational interventions. Of note, Michie and colleagues
[9] used a consensus approach, where four experts in health
and clinical psychology identified and classified 118
behavioral change techniques into 35 categories, and pro-
vided a consensus-based recommendation for each possible
combination of a TDF domain and a behavioral change
technique. The four possible recommendations were: 1)
should be used; 2) should not be used; 3) disagreed (for
combinations where consensus could not be reached); or 4)
uncertain (when not enough evidence was available in the
literature to take a position).
Recently, French and colleagues [10] integrated the
two aforementioned uses to propose a systematic four-
step method for the development of behavior-focused
interventions based on the TDF: 1) identify the behavior
to be changed; 2) identify barriers and enablers; 3) iden-
tify appropriate behavior change techniques; and 4) as-
sess changes in behavior.
The authors of this paper hypothesized that the TDF
could be used as part of an analysis plan to contextualize
and interpret findings from a needs assessment. More
specifically, we postulated that the TDF would provide a
rigorous structure by which results of a content-specific
needs assessment could be explained to a wider
audience, drive effective evidence-based KT, behavioral
change and educational strategies, and facilitate links be-
tween the needs assessment and the first three steps of
French’s development method [9]. This approach would
allow the findings and recommendations of a TDF-
mapped needs assessment to be readily interpreted by
health educators without detailed content knowledge.
To illustrate this hypothesis, the authors will present
and discuss a TDF post-hoc analysis of research findings
drawn from a 2012 national performance and educa-
tional needs assessment conducted with healthcare pro-
viders who treat and manage patients with growth and
growth hormone (GH) disorders.
Clinical background of the needs assessment
The Endocrine Society is a professional association of over
16,000 physicians and scientists involved in the study and
treatment of endocrine disorders. As part of its mission, it
strives to keep its members current on the management
and treatment of endocrine disorders, including growth
and GH disorders, a complex set of conditions that can
impact children, adolescents, and adults. Adult growth
hormone deficiency (AGHD) typically causes increased fat
mass, elevated LDL cholesterol levels, reduced bone min-
eral density, higher fracture rates, decreased muscle mass,
energy and quality of life [11]. Adults with excessive secre-
tion of GH have acromegaly, a chronic disease that can
cause high blood pressure, type 2 diabetes mellitus, in-
creased risk of cardiovascular disease, and arthritis [12].
Pediatric growth disorders (PGD) may have multiple eti-
ologies, including familial short stature, constitutional
delay, chronic non-endocrine disease, endocrine disorders,
nutritional deficits, and a variety of miscellaneous causes
including some genetic syndromes [13]. Based on the
etiology of the growth disorder, GH may be considered an
appropriate therapy. However, there are many issues for
endocrinologists to consider in regards to initiation
and continuation of therapy: effectiveness and safety of
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of continuing therapy, and transition from pediatric to
adult care [11,14,15].
Thus, The Endocrine Society undertook a behavioral
and educational needs assessment to better understand
the clinical challenges faced by physician providers in this
field (pediatric and adult endocrinologists, general pedia-
tricians), to determine their knowledge, skill, competency
and performance gaps, and to identify system issues that
interfere with effective diagnosis, management and treat-
ment of patients with growth and GH disorders. The
purpose of this needs assessment was to provide evidence-
based recommendations on how to design and deploy
effective educational interventions for physician providers
involved in the care of patients with GH or growth disor-
ders (pediatric and adult endocrinologists, general pedia-
tricians). The objective of this paper is to determine if
contextualizing the findings of this needs assessment
according to the TDF, in order to provide a broader and
more generalizable meaning to them, will simplify identifi-
cation of optimal educational interventions for these
endocrine care providers. We present the methodology of
the behavorial and educational needs assessment, analysis
of findings, contextualization and categorization according
to the TDF, and recommendations for optimal educational
strategies using the TDF categorization.
Methods
Given the complexity of evaluating, diagnosing, and
managing patients with growth and GH disorders, a
mixed-methods (qualitative and quantitative) behavioral
and educational needs assessment was selected. This ap-
proach incorporates the collection - and integrated ana-
lysis - of qualitative and quantitative data, drawing upon
the strengths and depth of qualitative exploratory data
collection and the analytic power of quantitative data
collection [16,17]. To improve trustworthiness of find-
ings [17,18], triangulation was employed, a technique
which consists of combining several research method-
ologies to respond to the same research question [19].
For this study, triangulation of approaches (qualitative,
quantitative), data collection methods (focus groups,
survey, cases), and data sources (i.e., pediatric endocri-
nologists, general pediatricians, adult endocrinologists)
were incorporated. In addition, a small sample of pa-
tients and caregivers was also interviewed, providing
complementary insights and perspectives on the chal-
lenges experienced by physicians, and thus indirectly,
on physicians’ needs. An overview of the research meth-
odology, including implementation timelines, is pro-
vided in Figure 1. Clinical aspects of the research design
were overseen by a steering committee of 5 Faculty, in-
cluding 2 endocrinologists, 2 pediatric endocrinologists,
and 1 general pediatrician (co-authors BMKB, MEM,
SMR, JLR and BDB). All steering committee members
are nationally-recognized experts in growth and GH
disorders and hold leadership positions within their in-
stitutions, participate on national treatment guideline
committees, and are part of Editorial Boards for peer-
reviewed publications.
Sampling and inclusion criteria
All participants were required to be actively practicing
in the United States. Pediatric endocrinologists were re-
quired to be providing care to children and/or teenagers
with PGD, representing a caseload of at least 10% of
their practice. General pediatricians were required to be
practicing in primary care settings and to be providing
care to children and/or teenagers with PGD, but no
minimal percentage of caseload was required. Adult en-
docrinologists were required to be providing care to a
minimum of 5 patients with AGHD or acromegaly per
year. In addition, specific criteria (region, clinical setting,
years of experience) were identified and employed in
purposive sampling. More precisely, a combination of
criterion sampling (where individuals meeting a specific
criteria are recruited) [20], and maximum variation sam-
pling (where individuals covering the spectrum of per-
spectives are recruited) [20], was used, with the aim of
obtaining a broad spectrum of perspectives that did not
significantly deviate from the characteristics of the na-
tional healthcare provider population [17,20].
Figure 1 Overview of methodology.
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prised a diagnosis of AGHD, acromegaly or PGD within
a minimum of six months prior to participation, and the
requirement to be actively followed by either an endo-
crinologist or a pediatric endocrinologist.
Recruitment and ethical considerations
Recruitment methods included faxes and e-mails to
potential participants from The Endocrine Society
national membership database (endocrinologists and
pediatric endocrinologists), the Magic Foundation
membership (patients and caregivers), an ad pub-
lished in the Hormone Hotline Newsletter, and a list
purchased from an external supplier (general pedia-
tricians). Independent ethical approval was obtained
from Institutional Review Board Services (IRB Ser-
vices, Aurora, Ontario, Canada) to ensure informed
consent, protection and confidentiality of partici-
pants, and respect of national and international
guidelines and policies on human subject research
[21,22]. Informed consent was obtained online from
all participants. All participants received ethically ac-
ceptable levels of compensation (i.e., market fair, but
not enough to create coercion) for their time, based
on the extent of their participation (survey or focus
group).
Qualitative data collection
Findings from a literature review informed the develop-
ment of guides used in semi-structured focus groups
(2 hours; pediatric and adult endocrinologists) and
semi-structured phone interviews (45 minutes; general
pediatricians). The two different collection methods
were selected to maximize the contribution of each
group of participants. Focus groups were selected for
the groups of physicians, allowing for dynamic and
interactive conversation and debate around controversies,
while individual interviews allowed for the facilitators to
respect each patient/caregiver’s level of comfort with the
topic [20,23]. Three different guides were used for the
physicians’ discussions in order to fit each provider’s
professional role. These guides included open-ended
questions and probes to stimulate discussion around chal-
lenges and barriers to the application of best practices in
the selection of a treatment plan for patients with GH de-
ficiency or excess. A sample of the qualitative questions is
presented in Table 1. Each focus group and interview was
audio-recorded with the consent of the participant(s), and
was carried out by experienced facilitators (co-authors PL
and SMH). The findings obtained from a preliminary ana-
lysis of the qualitative data (see analysis plan below for
more details) were used to lead the quantitative survey
development, and select the precise behaviors of inter-
est to be investigated through the quantitative phase
(see Table 1) [24].
Quantitative data collection
Questions were designed to either validate qualitative
findings through targeted questions, or to further
investigate the behaviors of interest determined by the
exploratory qualitative phase (see Table 1). The resulting
survey was developed as a series of quantitative
questions using multiple Likert-type scales, addressing
participants’: a) current level of knowledge, skill, and
confidence (1 =low; 5 =high); b) desired level of know-
ledge, skill, and confidence with regards to their role as
an endocrinologist, pediatric endocrinologist or general
pediatrician (1=low; 5 =high); c) perception of barriers
to optimal care (1=not a barrier; 5=a major barrier);
and d) clinical behaviors and attitudes (1 =almost never;
5=almost always). These scales have been used in
previous needs assessments in other therapeutic areas,
Table 1 Examples of questions used in the qualitative exploratory investigation, and examples of themes emerging
from qualitative data
Broad domains of
qualitative exploration
Example of exploratory qualitative questions
(no precise behaviors targeted)
Example of themes emerging from qualitative
data (i.e., behaviors to be further investigated)
Diagnosis What challenges do you experience in screening and
diagnosing growth disorders?
Screening and management of GH deficiency
Diagnosis of GH excess
Treatment What type of challenges (if any) do you experience
in your treatment choices?
Treatment criteria and guideline application in PGD
Multi-modal therapy for GH excess
Clinical decision-making regarding the choice of
treatment in acromegaly
Management What (if any) are your challenges in effectively managing
or monitoring your patients with growth disorders?
Ensuring smooth transition of care from childhood to
adulthood
Referrals from primary care pediatricians to Pediatric
Endocrinologists
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targeted providers [25-27]. Table 2 presents sample ques-
tions used in the survey. Clinical cases selected by the fac-
ulty steering committee were embedded in the survey to
assess clinical decision-making leading to treatment
choices. The use of case-based questions has been demon-
strated to be a valid tool for investigating potential clinical
practice gaps [28].
The surveys included questions common to all three
specialties and specific questions for each specialty, ensur-
ing adaptation to each provider’s role. Fourteen case stud-
ies were also included in the survey, four of which were
focused on GH deficiency, three on acromegaly and seven
on pediatric growth disorders: two were exclusively de-
signed for pediatric endocrinologists, two were designed
for general pediatricians, and three were designed for
both. Each case was design to investigate how providers
would manage a specific and realistic clinical situation that
faculty hypothesized to be particularly challenging.
Clinical cases were reviewed by all members of the
steering committee to ensure their validity, including
their agreement on which answer choices constituted
the best practice answer. Surveys were pilot tested
internally with an informed audience for face validity
and duration, and adjustments were made to ensure
clarity and respect of the allotted time.
Analysis plan
Facilitators completed a standardized form after each
focus group and interview to evaluate data quality.
Transcription of selected focus groups and interviews
was performed, based on these evaluations, until satur-
ation was achieved. Experienced qualitative researchers
(including co-authors PL and SMH) conducted the
analysis using N-Vivo 7.0 software
a. The approach
included three steps: data familiarization (where the
researcher immerses him/herself in the data), data
coding (where the researcher codes and classifies data
according to broad areas of interest), and theme identi-
fication (where the researcher identifies specific themes
with substantial data emerging from the domains of ex-
ploration investigated) [29,30]. Theme identification was
validated among researchers and discrepancies were
resolved through discussions until concordance was
achieved. Concordance was achieved in all cases. The
themes identified were then used to determine the behav-
iors of interest to be investigated through the quantitative
survey (Table 1).
Quantitative data from the first two series of survey
questions (current and desired levels of knowledge,
skill, and confidence) were analyzed using a method
called gap analysis, where the current levels are sub-
tracted from the desired levels to obtain a measure of
the gap between “what is” and “what should be” [3].
Using SPSS 12.0 software
b, frequencies and cross-
tabulations were obtained for the two remaining series
of questions (perception of barriers, and clinical behav-
iors and attitudes). Respondents’ answers to each of
the clinical cases were compared with optimal answers,
as identified by treatment guidelines and faculty
experts.
The aforementioned approaches, methods and sources
of data were triangulated to generate trustworthy and
reliable findings on the challenges experienced by endocri-
nologists, pediatric endocrinologists, and general pediatri-
cians in their provision of care to adult patients with
AGHD or acromegaly, or children/teenagers with PGD.
The different data sources were analyzed for comple-
mentarities, similarities and contradictions. The inter-
disciplinary group of researchers collectively reviewed
Table 2 Examples of questions and items used in the quantitative phase of the study
Category Examples of questions Scale anchors Examples of items
a) current level of knowledge,
skill, and confidence
Please select the number that best describes how you
currently evaluate your level of [knowledge/confidence/skill]
concerning each issue.
1 =low; 5=high The usefulness of using priming
substances in GH stimulation test
Considering all co-morbidities in the
selection of a treatment plan b) desired level of knowledge,
skill, and confidence with regards
to their role
Please indicate what you think is the required level of
[knowledge/confidence/skill] with regards to your role in
the care for patients with [GH deficiency/GH excess/PGD]
1 =low; 5=high
Negotiating patients’ resistance to
daily injection treatment
c) perception of barriers
to optimal care
Please indicate to what extent you think each of the
following is a barrier for you in providing optimal care
to patients [GH deficiency/GH excess/PGD].
1 =not a barrier;
5 =a major barrier
Worries about possible long-term
side-effects of growth hormone therapy
Patients’ resistance to daily injections
d) clinical behaviors and
attitudes
Please indicate to what extent you are following each
clinical practice behavior in providing care to patients
with [GH deficiency/GH excess/PGD]
1 =almost never;
5 =almost always
I generally avoid using growth
hormone stimulation tests because
I have no confidence in their value
When I propose a treatment to a
patient, I discuss the potential impact
on his/her quality of life
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gaps.
Post-hoc categorization of needs assessment findings
using the TDF
Categorization of the identified gaps was then under-
taken using the TDF. Each gap was categorized in one
or more of the 14 TDF domains, by an expert re-
searcher. The revised version of the TDF [4] was pre-
ferred to its original version [3] because the authors of
the revision demonstrated sufficient evidence-based sup-
port for the adjustments they proposed. A two-step
process was performed by 1) breaking down each gap
into its key underlying determinants, as identified in the
needs assessment, and 2) matching each of the gap’s de-
terminants with the most appropriate domain(s) of the
TDF. For example, a gap on proactive patient-provider
communication was broken down into 5 key underlying
determinants, and each determinant was matched with a
specific TDF domain: Lack of knowledge of existing
tools to facilitate communication (“Domain 1 – Know-
ledge”); Lack of skills in communicating efficiently with
patients (“2 – Skills”); Lack of confidence in discussing
specific topics with patients (“4 - Beliefs about Capabil-
ities”); Belief that patient will inquire if he/she has ques-
t i o n so rc o n c e r n s( “5 – Optimism”); and Underestimation
of impacts of miscommunications (“6 - Beliefs about Con-
sequences”). This analysis process was validated amongst
researchers, and discrepancies were resolved through dis-
cussions until concordance was achieved.
Linking of needs assessment findings to behavior change
techniques, through the TDF
Once educational gaps impacting the delivery of care re-
lated to PGD and adult GH disorders were broken down
into key underlying determinants and classified into TDF
domains, they were subsequently linked to consensus-
based behavior change techniques, using the four possible
consensus-based recommendation levels proposed by
Michie et al. [8]: 1) should be used; 2) should not be used;
3) disagreed, or 4) uncertain. The use of the TDF-based
map allowed identified challenges to be linked to behavior
change techniques that educational specialists could use
to bridge the educational gaps.
Results
Sample size and demographics
Responses from 225 providers were assessed; 30 from
the qualitative assessment and 195 from the quantitative
assessment. While the response rate could not be ob-
tained for the qualitative phase due to multiple channels
of participant recruitment, it was estimated to be at
12.9% for the quantitative phase, with a completion rate
of 3.8%. Table 3 provides the sample distribution and
demographic characteristics of the participants. Solo or
group practice settings accounted for 73% of pediatric
endocrinologists and general pediatricians, and 64% had
over 10 years of clinical experience. Providers practiced
predominantly in urban (45%) or suburban (49%) set-
tings. In addition, 15 patients or caregivers participated
in the qualitative phase of the study.
Identified gaps, challenges and barriers in the needs
assessment
A summary of the thirteen substantive gaps, challenges
and barriers that were identified is presented in Table 4. A
selection of illustrative quotes are available in Additional
file 1. Although the study included other topics, only re-
sults that led to the identification of educational needs are
presented. Because the study aimed to inform future edu-
cational initiatives, it focused on elements of care needing
improvement at the detriment of areas where care was
excellent.
Categorization of educational and performance gaps
by TDF
Each of the thirteen gaps, challenges and barriers were
linked post-hoc to one or more TDF domain, based on
the details of their underlying determinants. Results of
TDF-based categorization of the challenges identified by
the needs assessment are presented in the right-hand
column of Table 4. Potential determinants were revealed
from 9 of the 14 TDF domains. The domain “6 - Beliefs
about Consequences” was identified as a contributing de-
terminant to 7 of the 13 challenges. Five of the gaps
could be related to the “2 - Skills” domain, while three
were linked to the “1 -Knowledge” domain.
In order to respect space limitations, only the three
most substantive challenges will be detailed and dis-
cussed in this manuscript, specifically those related to
(A) Communication, (B) the complexities of the AGHD
and acromegaly treatment decision-trees, and (C) Tran-
sitions from childhood to adolescence and adulthood.
Details of TDF-based categorization of these three se-
lected challenges can be found in Table 5 and are dis-
cussed in detail below. The three challenges presented
cover all 9 TDF domains where determinants were iden-
tified, and should be sufficient to assess the value of
TDF as a categorization framework for educational and
behavioral needs assessment. For the ten remaining chal-
lenges identified, details of the TDF-based categorization
are available in Additional file 2.
Challenges in overcoming patient barriers and resistance
In AGHD, endocrinologists reported challenges in effect-
ively overcoming patient barriers and resistance related
to treatment, with 4 underlying determinants being
mapped to 5 of the TDF domains (Table 6). Specifically,
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as for patients and caregivers
Healthcare Providers Phase 1: Qualitative (n=30) Phase 2: Quantitative (n=195) TOTAL (n= 225)
Specialty
Endocrinologists 8 112 120 (53.3%)
Pediatric Endocrinologists 12 41 53 (23.6%)
General Pediatricians 10 42 52 (23.1%)
Gender
Men 20 108 128 (57.1%)
Women 10 86 96 (42.9%)
Region
Northeast 13 53 66 (29.3%)
Midwest 6 43 49 (21.8%)
South 5 59 64 (28.4%)
West 6 40 46 (20.4%)
Practice setting
Solo or group practice 20 144 164 (72.9%)
Community hospital or clinic 6 27 33 (14.7%)
Government hospital 0 11 11 (4.9%)
Academic Medical Center 4 5 9 (4.0%)
Other 0 8 8 (3.6%)
Years of practice
0-5 years of practice 1 35 36 (16.0%)
6-10 years 3 41 44 (19.6%)
11-20 years 13 71 84 (37.3%)
21-30 years 10 38 48 (21.3%)
More than 30 years 3 10 13 (5.7%)
Practice location
Urban 10 92 102 (45.3%)
Suburban 18 93 111 (49.3%)
Rural 2 10 12 (5.3%)
Patients & Caregivers
Adult patients with GH deficiency 5 N/A 5 (35.7%)
Caregivers of child with growth disorder 9 9 (64.3%)
Gender
Male 1 N/A 1 (7.7%)
Female 13 13 (92.3%)
Age of child
Age of child=0–6 years old 1 N/A 1 (11.1%)
Age of child=7–12 years old 4 4 (44.4%)
Age of child=13–18 years old 4 4 (44.4%)
Region
Northeast 1 N/A 1 (7.7%)
Midwest 1 1 (7.7%)
South 6 6 (42.9%)
West 6 6 (42.9%)
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tients’ resistance to daily injection treatment (43%), and
their communication skills in addressing patient resistance
(41%) are important barriers to care. In addition, 26% of
endocrinologists reported not always recommending
daily GH injections to avoid possible patient resistance,
even if it is perceived as the best treatment option. In
acromegaly, 47% of endocrinologists also see a barrier
in the patient’s resistance to injection treatment with a
medication that treats the excessive GH secretion. Ten
percent of endocrinologists have recommended another
treatment plan to avoid possible patient resistance, even
if the injections are the best treatment for that particu-
lar patient. Endocrinologists reported gaps in their skills
to communicate the value of treatment in AGHD (31%),
to explain the long-term benefits versus the short-term
adverse side-effects to asymptomatic patients (44%),
and to explain AGHD to patients in lay language (37%).
Forty-eight percent of endocrinologists stated they
have seen patients abandon treatment, due to their chal-
lenges in effectively communicating the benefits of GH
therapy in the absence of visible change. A gap in know-
ledge of existing tools to facilitate patient-provider com-
munication with AGHD patients was reported by 58%
of endocrinologists.
Pediatric endocrinologists and general pediatricians
identified a need for improved skills and confidence in
communicating with parents. Specifically, providers
expressed difficulty in dealing with parents seeking
treatment for their child who was short but considered
within a normal height range. Conversely, providers also
struggle with parents who did not perceive their child’s
growth deficiency as problematic, and were in denial.
Additional specific barriers that providers find difficult
to overcome include parents’ lack of understanding re-
garding their child’s disorder, and parents’ misinforma-
tion, through non-medical sources, about treatment
outcomes and long-term side effects of GH treatment.
The challenges in overcoming patient barriers and resist-
ance were linked to five TDF domains, through four under-
lying determinants. The first determinant reported was
communication skills, which was linked to TDF domain “2
- Skills”. Many of the detailed results within that challenge
were linked to the provider’s professional confidence, a
c o n s t r u c tt h a ti sp a r to fT D Fd o m a i n“4-B e l i e f sa b o u t
Capabilities”. A tendency was observed for providers to
downplay the consequences of some of their communica-
tion challenges, not always realizing that a lack of commu-
nication can lead to a misinformed patient who may then
make a misinformed choice. This tendency is linked to
both “6 - Beliefs about Consequences”,a n d“5-O p t i m i s m ”.
Finally, there is an aspect of this issue that can be linked to
“1-K n o w l e d g e ”, specifically regarding patient – provider
communication tools.
Challenges with the AGHD and Acromegaly treatment
decision-tree
Five underlying determinants of endocrinologists’ gap in
AGHD treatment decisions were identified and linked
post-hoc to 5 TDF domains (Table 5). In AGHD,
Table 4 List of substantive gaps, challenges and barriers identified (items in bold are the focus of this article), with
their corresponding TDF domain(s)
# Challenge AGHD Acromegaly PGD TDF Domains*
1 Challenges communicating with patients, especially in overcoming patients’
barriers and resistances
X X X 1 ,2 ,4 ,5 ,6
2 Challenges with the treatment decision-tree X X — 1, 2, 4, 9, 10
3 Challenges associated with the transition from childhood to teen years, to adulthood ——X 1 ,2 ,3 ,4 ,6 ,1 1
4 Insurance companies processes interfere with clinical decisions X X X 11
5 Use of appropriate materials to support patient education X X X 1, 11
6 Referrals between general pediatricians and pediatric endocrinologists
(timeliness, appropriate pre-testing)
——X 1 ,4 ,6
7 Perceptions of GH therapy X —— 6
8 Lack of clarity in roles and responsibilities X X X 3
9 Application of diagnostic tests X — X2 , 4
10 Lack of screening by primary care — X — 6
11 Identifying tests needed for at risk co-morbidities ——X2 , 6
12 Presenting Treatment as optional X —— 6
13 Inconsistencies between labs (system) X X X 11
* “1 – Knowledge”; “2 – Skills”; “3 - Social/Professional Role and Identity”; “4 - Beliefs about Capabilities”; “5 – Optimism”; “6 - Beliefs about Consequences”;
“7 – Reinforcement”; “8 – Intentions”; “9 – Goals”; “10 - Memory, Attention, and Decision Processes”; “11 - Environmental Context and Resources”; “12 - Social Influences”;
“13 – Emotion”; and “14 - Behavioral Regulation”.
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AGHD once diagnosed (39%), determining if adverse
side-effects outweigh long term benefits of treatment
(55%), and adjusting dosage of therapy to minimize ad-
verse side-effects (51%).
Similarly in acromegaly, confidence gaps were reported
in making the appropriate clinical decisions when man-
aging uncured post-operative acromegaly (61%), deciding
how long to wait before trying another medical option
that provides biochemical control (64%), and recom-
mending alternate treatment options, should the first
medical treatment selected not provide biochemical con-
trol (67%).
In addition, endocrinologists reported gaps in their skills
to select the appropriate treatment option when managing
uncured post-operative acromegaly (49%), and in recom-
mending alternate treatment options, should the first
medical treatment selected not provide biochemical con-
trol (53%).
Providers also expressed challenges in monitoring
benefits and side-effects associated with GH therapy in
AGHD (46%), and in assessing the impact of GH re-
placement on quality of life (52%). Additionally, 48% of
endocrinologists reported a gap in their knowledge of
the extent to which short-term side-effects compare to
long term benefits of treatment in patients with AGHD.
The underlying determinants of the AGHD and acro-
megaly treatment decision-trees challenges were linked
to five of the TDF domains. Several specific issues were
linked to the provider’s “2 – Skills”,a n ds e v e r a lo t h e r s
were linked to professional confidence, a construct that
is part of TDF domain “4 - Beliefs about Capabilities”.
The issues described above will affect decision-making,
a construct that the TDF authors have classified into the
“10 - Memory, Attention, and Decision Processes” do-
m a i n .F i n a l l y ,o n ei s s u eo f“1 – Knowledge” was reported
by the endocrinologists (comparison of short-term side-
effects to long term benefits of treatment in patients
with AGHD). In-depth analysis can also link this same
issue to the “9 – Goals” domain, through the two con-
structs of distal vs. proximal goals and goal priority.
Challenges associated with the transition from childhood to
teen years to adulthood
Six underlying determinants were identified for chal-
lenges associated with the transition from childhood to
teen years to adulthood, and were linked post-hoc to 6
of the TDF domains (Table 5). Of note, pediatric
Table 5 List of the three most substantive gaps, challenges and barriers identified, with results of their secondary
analysis using TDF domains
# Challenge TDF Domain Underlying determinant of the Challenge
1 Challenges in overcoming patient barriers
and resistance
“1 – Knowledge” Lack of knowledge of tools to facilitate patient – provider
communication
“2 – Skills” Lack of communication skills
“4 - Beliefs about Capabilities” Lack of confidence
“5 – Optimism” Underestimation of impacts of miscommunications
“6 - Beliefs about Consequences”
2 Challenges with the treatment decision-tree “1 – Knowledge” Extent to which short-term adverse side-effects compare to
long term benefits of treatment in patients with AGHD
“2 – Skills” Challenge in balancing long term benefits of treatment with
short-term adverse effects
“4 - Beliefs about Capabilities” Confidence issues
“9 – Goals” Prioritization between proximal goal of avoiding side effects
and distal goal of avoiding long-term consequences of disorder
“10 - Memory, Attention,
and Decision Processes”
Specific challenges in the clinical reasoning process
3 Challenges associated with the transition
f r o mc h i l d h o o dt ot e e ny e a r s ,t oa d u l t h o o d
“1 – Knowledge” Consequences of inappropriate cessation of GH therapy
“2 – Skills” Lack of skills in addressing compliance during teenage years
“3 - Social/Professional Role
and Identity”
Lack of clarity on which tests should be done at primary
care levels and which ones should be done by specialists
“4 - Beliefs about Capabilities” General pediatricians preferring to refer because of lack of
confidence
“6 - Beliefs about Consequences” Underestimation of impact of growth hormone treatment
cessation
“11 - Environmental Context
and Resources”
Lack of adult-treating endocrinologists forcing pediatric
endocrinologists to keep patients under their management longer
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http://www.biomedcentral.com/1472-6963/14/319Table 6 Recommendations on behavior change techniques (as per Michie 2008 [4] see original article for description of
each technique category) for each underlying determinant within the three most substantive gaps, challenges and
barriers identified
TDF Domain Identified challenges (underlying determinant) Techniques Recommendations (All other techniques are
in the “agreed non-use” category)
1 - Knowledge Challenges in overcoming patient barriers and resistance
(Lack of knowledge of tools to facilitate patient – provider
communication)
Agreed use: Information regarding behavior, outcome
Uncertain: goal/target specified: behavior or outcome//
Persuasive communication
Disagreement: Personalized message//Homework
Challenges with the treatment decision-tree (Extent to which
short-term adverse side-effects compare to long
term benefits of treatment in patients with AGHD)
Challenges associated with the transition from childhood
to teen years, to adulthood (Consequences of
inappropriate cessation of GH therapy)
2 -Skills Challenges in overcoming patient barriers and resistance
(Lack of communication skills)
Agreed use: goal/target specified: behavior or outcome//
Monitoring//Self-monitoring//rewards & incentives//
Graded tasks//problem-solving, decision-making,
goal-setting//Rehearsal//Modeling, demonstration
of behavior//Homework//perform behavior in different
settings//problem-solving
Challenges with the treatment decision-tree (balancing long
term benefits of treatment with short-term adverse effects)
Uncertain: Stress management//Planning, implementation
Challenges associated with the transition from childhood
to teen years, to adulthood (Lack of skills in addressing
compliance during teenage years)
Disagreement: Coping skills//Role-play//Feedback//Shaping
of behavior
3 - Social/Professional
Role and Identity
Challenges associated with the transition from childhood
to teen years, to adulthood (Lack of clarity on which tests
should be done at primary care levels and which ones
should be done by specialists)
Agreed use: Social process of encouragement, pressure,
support
Uncertain: Contract//rewards & incentives//problem-solving,
decision-making, goal-setting//Role-play//Environmental
changes//Persuasive communication//Personalized message//
feedback
Disagreement: Information regarding behavior, outcome//
Modeling, demonstration of behavior//Cognitive restructuring
4 - Beliefs about
Capabilities
Challenges in overcoming patients’ barriers and resistances
(Lack of confidence)
Agreed use: Self-monitoring//Graded tasks//problem-solving,
decision-making, goal-setting//Social process of
encouragement, pressure, support//Feedback//self-talk//
Motivational interviewing Challenges with the treatment decision-tree (Lack of
confidence)
Uncertain: Monitoring//rewards & incentives//Coping skills//
Rehearsal//Stress management//Information regarding
behavior, outcome//Personalized message//Experiential//Use
of imagery//perform behavior in different settings//Shaping of
behavior//Relapse prevention//Identify-prepare for difficult
situations, problems
Challenges associated with the transition from childhood
to teen years, to adulthood (General pediatricians
preferring to refer because of lack of confidence)
Disagreement: −
5 - Optimism Challenges in overcoming patients’ barriers and resistances
(Underestimation of impacts of miscommunications)
Agreed use: Self-monitoring//Graded tasks//problem-solving,
decision-making, goal-setting//Social process of
encouragement, pressure, support//Feedback//self-talk//
Motivational interviewing
Uncertain: Monitoring//rewards & incentives//Coping skills//
Rehearsal//Stress management//Information regarding
behavior, outcome//Personalized message//Experiential//Use
of imagery//perform behavior in different settings//Shaping of
behavior//Relapse prevention//Identify-prepare for difficult
situations, problems
Disagreement: Role-Play//Persuasive communication//
Modeling, demonstration of behavior//Homework//Personal
experiments//Cognitive restructuring
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to respond to caregivers’ concerns about the impact of
PGD on puberty. Two thirds of providers perceived the
facilitation of treatment compliance following the onset
of puberty as a frequent struggle. Adult endocrinologists
expressed similar issues in taking on young adult
patients, highlighting their need for enhanced competen-
cies in addressing management of GHD with that
sub-population. Additionally, providers identified that
negotiating conflicts between teenagers and their parents
with regards to treatment choice, and supporting pa-
tients in coping with the possibility of lifelong treatment,
also required improved competencies. Furthermore, half
of pediatric endocrinologists reported continuing to care
for patients with GHD into their mid-20s, either because
they perceived it was better for the patient, or because
they could not find an adult endocrinologist that would
take on the patient. A related treatment gap in endocri-
nologists’ knowledge of the consequences of cessation
of GH therapy in patients who remain deficient was also
identified. Only 58% of endocrinologists selected the
correct answer for the case developed on this issue
highlighting an important knowledge gap.
The underlying determinants of the challenges asso-
ciated with the transition periods were linked to six
TDF domains. There is an issue of “1 – Knowledge” re-
ported by the endocrinologists (consequences of
cessation of GH therapy in patients who remain defi-
cient), that also linked to the domain of “6 - Beliefs
about Consequences”. Facilitation of treatment compli-
ance and several other issues can be linked to domain
“2 – Skills”. There are also underlying determinants
that can be attributed to “3 - Social/Professional Role
and Identity”, as there is a lack of clarity on which tests
should be done at primary care levels and which ones
should be done by specialists. General pediatricians
preferring to refer due to lack of confidence can be
linked to TDF domain “4 - Beliefs about Capabilities”.
Finally, “11 - Environmental Context and Resources” is
also a determinant, specifically when pediatric endocri-
nologists report managing patients for longer because
they were unable to find an adult endocrinologist who
would treat their patient for GHD.
Discussion
The authors hypothesized that Theoretical Domains
Framework (TDF) could provide a valuable structure for
the post-hoc categorization and interpretation of findings
from an educational needs assessment conducted in
growth and GH disorders, as a means to provide deeper
understanding of the identified gaps, and readily utilizable
direction to plan educational activities. This approach can
provide insights to educators to develop effective and tar-
geted KT and educational interventions, and to more
Table 6 Recommendations on behavior change techniques (as per Michie 2008 [4] see original article for description of
each technique category) for each underlying determinant within the three most substantive gaps, challenges and
barriers identified (Continued)
6 - Beliefs about
Consequences
Challenges in overcoming patients’ barriers and resistances
(Underestimation of impacts of miscommunications)
Agreed use: Self-monitoring//Persuasive communication//
Information regarding behavior, outcome//Feedback
Uncertain: Monitoring//rewards & incentives//Role-play//
Personalized message//Personal experiments
Challenges associated with the transition from childhood to
teen years, to adulthood (Underestimation of impact of
growth hormone treatment cessation)
Disagreement: goal/target specified: behavior or outcome//
Homework//Motivational interviewing//Cognitive
restructuring
9 - Goals Challenges with the treatment decision-tree (prioritization
between proximal goal of avoiding side effects and distal goal
of avoiding long-term consequences of disorder)
Agreed use: Social process of encouragement, pressure,
support//Modeling, demonstration of behavior
Uncertain: Monitoring//rewards & incentives//Role-play//
persuasive communication//homework
Disagreement: Contract
10 - Memory, Attention,
and Decision Processes
Challenges with the treatment decision-tree
(Specific challenges in the clinical reasoning process)
Agreed use: Self-monitoring//Planning, implementation//
Prompts, triggers, cues
Uncertain: Monitoring//rewards & incentives//Graded tasks//
problem-solving, decision-making, goal-setting//stress
management//Rehearsal//Personalized message//Personal
experiments//feedback//self-talk//use of imagery//perform
behavior in different settings//Time management
Disagreement: Environmental changes
11 - Environmental
Context and
Resources
Challenges associated with the transition from childhood to
teen years, to adulthood (Lack of adult-treating
Endocrinologists forcing Pediatric Endocrinologists to keep
patients under their management longer)
Agreed use: Environmental changes
Uncertain: Prompts, triggers, cues
Disagreement: −
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without requiring expertise in that content area.
A total of 13 challenges impacting the delivery of care
related to PGD and adult GH disorders were broken
down into key underlying determinants, classified into
TDF domains, and subsequently linked to consensus-
based behavior change techniques, using Michie et al.’s
[4] proposed TDF-based map. Table 6 presents the rec-
ommendations from TDF-based map for the three most
substantive challenges identified in this study, broken
down into their underlying determinants.
The process of categorizing the behavioral and educa-
tional gaps according to TDF was clear, and no gaps
were left without a linked domain. Two pairs of do-
mains appear slightly more difficult to distinguish: “5 –
Optimism” and “6 - Beliefs about Consequences”,a sw e l l
as “8 – Intentions” and “9 – Goals”.H o w e v e r ,t h ed e f i n i -
tions provided by Cane and colleagues [2] helped re-
solve and classify the gaps appropriately. Five domains
were not used in this classification process: “7 –
Reinforcement”; “8 – Intentions”; “12 - Social Influences”;
“13 – Emotion”;a n d“14 - Behavioral Regulation”.T h a t
does not mean that there are no causal links between
gaps and those domains, but rather that no evidence
allowed the authors to make such links.
The value behind categorizing behavioral and educa-
tional gaps according to TDF lies in the identification of
multiple variables that might have been otherwise
neglected, had the specific gap not been analyzed and
classified into underlying determinants. In addition, dis-
secting gaps into their underlying determinants for clas-
sification into the 14 TDF domains opens the door to a
broad inventory of evidence-based behavior change tech-
niques that could be used to address the specific needs
identified. As such, it allows educators who are not ex-
perts in a specific domain (e.g., are not PGD/AGHD/Ac-
romegaly specialists) to apply the findings. Linking each
TDF domain to multiple behavior change techniques fa-
cilitates efficient identification of optimal learning tech-
niques for a given gap by educators and KT strategists.
Alternatively it allows combination of multiple tech-
niques, optimizing the possibility of meeting the learning
preferences of each learner. It is hypothesized that pre-
senting needs assessment findings mapped to TDF do-
mains could facilitate use by educators, as it traces a
path between the first three steps of French’s four-step
systematic method for development of behavioral change
interventions [7]. In addition, the range of behavioral
change techniques available through TDF categorization
of gaps enables educators to develop learning curricula
that follow educational logic, and can affect behaviors in
an optimal sequence. For example, TDF categorization
for the AGHD and acromegaly treatment decision-tree
delineates that learning curricula should first address
clinicians’ knowledge of short-term side effects and long
term benefits of treatment through informational, didac-
tic sessions. This should be followed by interventions
such as problem-solving and graded tasks that target
their skills in balancing those short and long term conse-
quences of treatment (Table 6). This allows clinicians to
concentrate on treatment goal prioritization through be-
havioral modeling exercises. Finally, and perhaps most
importantly, while the TDF facilitates communication
and understanding of issues influencing optimal KT in
growth and GH disorders in the context of this manu-
script, because it is not tied to any specific approach, it
does not require any understanding or knowledge of
endocrinology as a subject matter.
While most medical societies develop interventions
to address the full scope of medical knowledge in their
specialty, relatively few regularly produce interventions
addressing the full range of Accreditation Council of
Graduate Medical Education competencies [31] (e.g. inter-
personal and communication skills, professionalism,
practice-based learning and improvement, systems based
practice). As medical specialty societies strive to enhance
educational value and measure the efficacy of educational
interventions on clinician performance and patient health
outcomes, they must engage in more robust needs assess-
ment methodologies that not only identify gaps, but
contextualize their underlying determinants, and facilitate
translation of the findings into KT or educational activities.
TDF-framed needs assessment outcomes lend integrity
and urgency to investment in producing new educational
interventions for clinicians treating growth and GH dis-
orders. For example, these findings highlight the need to
address the challenges inherent to the transition of care
for patients with GHD from the pediatric to adult endo-
crinologist. While traditional didactic interventions raise
awareness of the need for additional vigilance by
providers, this report suggests the opportunity for re-
sources, such as clinical practice guidelines specifically
addressing transitions of care for all the providers along
this continuum. In addition, the findings place new em-
phasis on addressing physician to patient (or caregiver)
communication, and suggest the opportunity to develop
talking guides for all providers, patients and their
caregivers. Likewise, distinct educational interventions
for adolescent patients and their caregivers are being
considered.
Limitations
Categorization using TDF was a post-hoc analysis to better
understand findings from a behavioral and performance
needs assessment that had not been designed with TDF in
mind. Despite efforts on the researchers’ part to the con-
trary, classification of the different causal variables of the
gaps into TDF domains remains partly subjective. In
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needs assessment may have provided subjective interpreta-
tions of their contextual issues. Triangulation was used to
strengthen the trustworthiness of the findings and to limit
t h es u b j e c t i v i t yi n h e r e n tt os e l f - a s s e s s m e n t .T h e r ei sap o s -
sibility of self-selection bias, as participation in this study
was voluntary. However, selective sampling was used to in-
crease probability of having a sample that is representative
of the targeted population. Finally, the relatively small sam-
ple size of patients and caregivers is not an important limi-
tation to the study, considering they were not a direct
target population, but rather their involvement was to en-
rich the mixed-methods triangulated approach.
Conclusions
Results from this national needs assessment illustrate the
links that can be made between behavioral and educational
needs assessment findings and TDF. The question remains
as to whether TDF model should be used a priori (i.e. in
the planning phases of assessments of gaps) or a posteriori
(i.e. in the interpretation phases of needs assessments).
While both approaches seem to be suitable, the selection of
either approach would depend on the objectives and scope
of the initiative. A knowledge translator or educator who is
seeking to further his understanding of a specific gap may
want to consider using the a priori approach through a
TDF methodology for instance, while another who is inter-
ested in exploring challenges and barriers in a therapeutic
area may want to conduct a posteriori TDF analyses follow-
ing a broader needs assessment.
Educational specialists who are preparing needs as-
sessments should be aware of new developments and
theories in the fields KT and behavioral change. For the
educational cycle to reach its optimum potential, there
needs to be continuity between those who assess needs
and those who address the needs (i.e. education and KT/
behavioral change specialists).
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